Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Armand

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Oncogene|March 16, 1995
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesionsJ C Ahomadegbe, M Barrois, S Fogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomasJ Bourhis, A Fortin, O Dupuis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal typeN Azli, J P Armand, M Rahal, et al.
Cancer Treatment Reports|June 1, 1986
Phase II clinical evaluation of doxifluridineP Hurteloup, J P Armand, P Cappelaere, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayJ Bonneterre, H Coppens, L Mauriac, et al.
The Cancer Journal From Scientific American|October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal typeN Azli, A Fandi, M Bachouchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal typeA Fandi, M Bachouchi, N Azli, et al.
The Laryngoscope|March 1, 1992
Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomasT Guillot, M Spielmann, J Kac, et al.
Bulletin Du Cancer|March 1, 1996
[High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium]S Fogel, J C Ahomadegbe, M Barrois, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Oncogene|March 16, 1995
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesionsJ C Ahomadegbe, M Barrois, S Fogel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomasJ Bourhis, A Fortin, O Dupuis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal typeN Azli, J P Armand, M Rahal, et al.
Cancer Treatment Reports|June 1, 1986
Phase II clinical evaluation of doxifluridineP Hurteloup, J P Armand, P Cappelaere, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayJ Bonneterre, H Coppens, L Mauriac, et al.
The Cancer Journal From Scientific American|October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal typeN Azli, A Fandi, M Bachouchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal typeA Fandi, M Bachouchi, N Azli, et al.
The Laryngoscope|March 1, 1992
Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomasT Guillot, M Spielmann, J Kac, et al.
Bulletin Du Cancer|March 1, 1996
[High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium]S Fogel, J C Ahomadegbe, M Barrois, et al.
Pageof 15